Hua Xu

8.0k total citations
183 papers, 5.3k citations indexed

About

Hua Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hua Xu has authored 183 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 56 papers in Cancer Research and 55 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hua Xu's work include Cancer-related molecular mechanisms research (21 papers), Prostate Cancer Treatment and Research (20 papers) and Kidney Stones and Urolithiasis Treatments (18 papers). Hua Xu is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), Prostate Cancer Treatment and Research (20 papers) and Kidney Stones and Urolithiasis Treatments (18 papers). Hua Xu collaborates with scholars based in China, United States and Macao. Hua Xu's co-authors include Zhangqun Ye, Kun Tang, Heng Li, Yu Gan, Haibing Xiao, Wei Xiao, Jef D. Boeke, Wei Guan, Ke Chen and Weimin Yao and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Hua Xu

177 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Xu China 43 3.1k 1.8k 1.1k 743 512 183 5.3k
Yinghao Sun China 40 2.5k 0.8× 1.8k 1.0× 1.4k 1.3× 580 0.8× 728 1.4× 167 4.7k
Liping Xie China 42 3.1k 1.0× 1.9k 1.1× 962 0.9× 644 0.9× 507 1.0× 220 5.3k
Tao Wang China 42 4.0k 1.3× 2.3k 1.3× 848 0.8× 1.0k 1.4× 791 1.5× 284 6.3k
Xu Chen China 48 3.9k 1.3× 2.0k 1.1× 886 0.8× 1.2k 1.6× 965 1.9× 277 6.9k
Pei Ma China 33 3.4k 1.1× 2.4k 1.3× 640 0.6× 439 0.6× 304 0.6× 102 4.7k
Xiangyi Zheng China 39 2.4k 0.8× 1.7k 0.9× 691 0.6× 470 0.6× 492 1.0× 138 4.1k
Antonia Vlahou Greece 42 3.1k 1.0× 628 0.4× 635 0.6× 560 0.8× 1.0k 2.0× 198 6.1k
Adeboye O. Osunkoya United States 42 2.0k 0.6× 926 0.5× 2.4k 2.2× 1.1k 1.4× 1.1k 2.2× 194 5.7k
Sheng Tai China 29 1.7k 0.5× 1.0k 0.6× 528 0.5× 478 0.6× 459 0.9× 110 3.6k
Tomoaki Fujioka Japan 35 1.8k 0.6× 619 0.4× 874 0.8× 774 1.0× 679 1.3× 173 3.8k

Countries citing papers authored by Hua Xu

Since Specialization
Citations

This map shows the geographic impact of Hua Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Xu more than expected).

Fields of papers citing papers by Hua Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Xu. The network helps show where Hua Xu may publish in the future.

Co-authorship network of co-authors of Hua Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Xu. A scholar is included among the top collaborators of Hua Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Xu. Hua Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Minghui, Yanfang Guan, Chen Duan, et al.. (2025). Trans-ancestry GWAS identifies 59 loci and improves risk prediction and fine-mapping for kidney stone disease. Nature Communications. 16(1). 3473–3473. 1 indexed citations
2.
Hu, Junhui, Ping Tan, Nicholas Bayley, et al.. (2023). Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduction and Targeted Therapy. 8(1). 155–155. 40 indexed citations
3.
Shao, Jianbo, Hong Xu, Zhixi Liu, et al.. (2021). Factors associated with the time to return negative RT-PCR from COVID-19 in paediatric patients: a retrospective cohort study. BMJ Open. 11(10). e052609–e052609.
4.
Xu, Hua, et al.. (2021). Model-Oriented Dose Optimization of Voriconazole in Critically Ill Children. Antimicrobial Agents and Chemotherapy. 65(9). e0049321–e0049321. 15 indexed citations
6.
Chen, Ke, Jin Zeng, Yi Eve Sun, et al.. (2021). Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma. Cancer Communications. 41(4). 316–332. 11 indexed citations
7.
Xu, Hua, et al.. (2020). Primary low-grade myofibroblastic sarcoma: A rare case report of this tumor in the orbit and literature review. European Journal of Ophthalmology. 32(2). NP67–NP70. 5 indexed citations
8.
Yuan, Peng, Ejun Peng, Xia Ding, et al.. (2020). Risk Factors for Urosepsis after Minimally Invasive Percutaneous Nephrolithotomy in Patients with Preoperative Urinary Tract Infection. BioMed Research International. 2020(1). 1354672–1354672. 15 indexed citations
9.
Zhang, Yucong, Beichen Ding, Guoliang Sun, et al.. (2019). The impact of ambient temperature on the incidence of urolithiasis: a systematic review and meta-analysis. Scandinavian Journal of Work Environment & Health. 46(2). 117–126. 16 indexed citations
10.
Hu, Junhui, Wei Guan, Libin Yan, et al.. (2019). Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma. Stem Cells International. 2019. 1–9. 25 indexed citations
11.
Zhu, Yu, Hua Xu, Yao Zhu, et al.. (2017). A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length. Journal of Cancer. 9(2). 269–274. 9 indexed citations
12.
Xu, Jun, Yonghui Wu, Yaoyun Zhang, & Hua Xu. (2017). Detecting Body Location Modifiers of Disorders in Clinical Texts via Sequence Labeling.. AMIA. 1 indexed citations
13.
Xu, Hua, Mengbo Hu, Peide Bai, et al.. (2015). Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet. BioMed Research International. 2015. 1–7. 37 indexed citations
14.
Gan, Yu, Weimin Yao, Kiranmai Gumireddy, et al.. (2014). Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression. Molecular Cancer Therapeutics. 13(12). 3086–3097. 166 indexed citations
15.
Gumireddy, Kiranmai, Anping Li, Andrew V. Kossenkov, et al.. (2014). ID1 Promotes Breast Cancer Metastasis by S100A9 Regulation. Molecular Cancer Research. 12(9). 1334–1343. 35 indexed citations
16.
Cao, Maosen, et al.. (2014). Structural dynamics-guided hierarchical neural-networks scheme for locating and quantifying damage in beam-type structures. Journal of Vibroengineering. 16(7). 3595–3608. 5 indexed citations
17.
Gan, Yu, Weimin Yao, Wei Xiao, et al.. (2014). MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. Journal of Experimental & Clinical Cancer Research. 33(1). 779–779. 92 indexed citations
18.
Chang, Lei, Runlin Shi, Tao Yang, et al.. (2013). Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity. Journal of Experimental & Clinical Cancer Research. 32(1). 101–101. 15 indexed citations
19.
Xu, Hua, Melinda C. Aldrich, Qingxia Chen, et al.. (2012). Electronic health record data suggests metformin improves cancer survival: A new model for drug repurposing studies.. AMIA. 1 indexed citations
20.
Wu, Xiujie, Shuangwei Zhang, Yin Zhao, et al.. (2012). Spatiotemporal patterns and essential role of TNF receptor-associated factor 5 expression after rat spinal cord Injury. Journal of Molecular Histology. 43(5). 527–533. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026